Security key
810648105
scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH)
CUSIP: 810648105
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 39,775,602
- Total 13F value
- $140,807,820
- Share change
- +2,402,710
- Put/Call ratio
- 15%
- SEC-reported price per share
- $3.54
- Number of holders
- 84
- Value change
- +$5,279,129
- Number of buys
- 46
- Number of sells
- 40
- Shares outstanding
- 53,364,241
Holder snapshot
7 signals
Show 1 more signal
Security identity
Who this page is about.
1 source field
Report period
Q4 2024
Institutions
84
Top holders
10
SCPH full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2025
Previous quarter: Q3 2024
scPharmaceuticals Inc. SEC filings
scPharmaceuticals Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 810648105
Recent filing periods:
Ownership snapshot
Top reported holders of SCPH - scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ORBIMED ADVISORS LLC
Disclosed value leader
ORBIMED ADVISORS LLC
Comparable rows
15/15
Latest evidence
30 Sep 2024
13F
3/4/5
Lead comparable stake: 11%
Showing 1-6 of 15 holder rows.
Quick read
ORBIMED ADVISORS LLC leads the comparable SEC ownership view at 11%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ORBIMED ADVISORS LLC's linked filing trail.
Comparable ownership
Top 5
ORBIMED ADVISORS LLC
11%
Rubric Capital Management LP
8.9%
AIGH Capital Management LLC
7.7%
KING LUTHER CAPITAL MANAGEMENT CORP
4.2%
SUVRETTA CAPITAL MANAGEMENT, LLC
3.8%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
3/4/5
Company · 10%+ Owner
|
11%
|
$27,631,448
6,059,528 shares
|
— | 30 Sep 2024 |
| Rubric Capital Management LP |
13F
Company
|
8.9%
|
$21,774,000
4,775,000 shares
|
— | 30 Sep 2024 |
| AIGH Capital Management LLC |
13F
Company
|
7.7%
|
$18,807,113
4,124,367 shares
|
— | 30 Sep 2024 |
| KING LUTHER CAPITAL MANAGEMENT CORP |
13F
Company
|
4.2%
|
$10,149,602
2,225,790 shares
|
— | 30 Sep 2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
Company
|
3.8%
|
$9,343,481
2,049,009 shares
|
— | 30 Sep 2024 |
| BlackRock, Inc. |
13F
Company
|
3.5%
|
$8,453,095
1,853,749 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
84
Shares
39,775,602
Rows available
84
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
93
Q4 2024 holders
84
Holder diff
-9
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 value | Q4 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend